Kestra Medical Technologies (KMTS) released its Q4 2025 financial results after market close.
The company reported revenue of $17.23 million, surpassing estimates of $15.75 million by 9.46%.
Adjusted earnings showed a loss of $1.15 per share, wider than the estimated loss of $0.53 per share.
For FY 2026, Kestra Medical projects revenue of $85.00 million.
